This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Subhankar Panda: Innovator in Antiviral Research
Introduction
Subhankar Panda is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of antiviral research, particularly in the development of next-generation remdesivir antivirals. His work focuses on innovative compounds that aim to combat serious pulmonary infections.
Latest Patents
Subhankar Panda holds 1 patent for his groundbreaking work on next-generation remdesivir antivirals. The patent disclosure relates to compounds of the formula (I) and (II), which are pharmaceutical compositions designed to treat pulmonary infections caused by viruses such as SARS-COV, MERS-COV, and SARS-COV-2. This invention represents a crucial advancement in the fight against viral infections.
Career Highlights
Panda is affiliated with the Regents of the University of Minnesota, where he conducts his research and development. His academic and professional background has equipped him with the expertise necessary to innovate in the field of pharmaceuticals. His dedication to improving antiviral treatments has positioned him as a key figure in this area of research.
Collaborations
One of his notable collaborators is Tej Poudel. Together, they work on advancing antiviral therapies and exploring new avenues for treatment.
Conclusion
Subhankar Panda's contributions to antiviral research, particularly through his patent on remdesivir antivirals, highlight his commitment to addressing critical health challenges. His work continues to pave the way for innovative solutions in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile